Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG)

Author:

Qi Shu-Nan1,Xu Li-Ming2,Yuan Zhi-Yong2,Wu Tao3,Zhu Su-Yu4,Shi Mei5,Su Hang6,Wang Ying7,He Xia8,Zhang Li-Ling9,Wu Gang9,Qu Bao-Lin10,Qian Li-Ting11,Hou Xiao-Rong12,Zhang Fu-Quan12,Zhang Yu-Jing13,Zhu Yuan14,Cao Jian-Zhong15,Lan Sheng-Min15,Wu Jun-Xin16,Yang Yong1ORCID,Li Ye-Xiong1

Affiliation:

1. State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Center for Cancer Precision Medicine, CAMS and PUMC, National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, P. R. China;

2. Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, P. R. China;

3. Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, P. R. China;

4. Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, P. R. China;

5. Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China;

6. 307 Hospital, Academy of Military Medical Science, Beijing, P. R. China;

7. Chongqing Cancer Hospital & Cancer Institute, Chongqing, P. R. China;

8. Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, P. R. China;

9. Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China;

10. The General Hospital of Chinese People's Liberation Army, Beijing, P. R. China;

11. The Affiliated Provincial Hospital of Anhui Medical University, Hefei, P. R. China;

12. Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, P. R. China;

13. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China;

14. Zhejiang Cancer Hospital, Hangzhou, Zhejiang, P. R. China;

15. Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, P. R. China;

16. Fujian Provincial Cancer Hospital, Fuzhou, P. R. China

Funder

National Key Projects of Research and Development of China

Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3